Waldencast Acquisition Corp Cash Flow Conversion Efficiency
Waldencast Acquisition Corp cash flow conversion efficiency. Based on the latest financial reports, Waldencast Acquisition Corp (WALDW) has a cash flow conversion efficiency ratio of -0.003x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.29 Million) by net assets ($500.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Waldencast Acquisition Corp (2020–2025)
Cash flow conversion efficiency of Waldencast Acquisition Corp from 2020 to 2025. This chart illustrates how Waldencast Acquisition Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Waldencast Acquisition Corp stock quote for real-time trading data and today's change.
Waldencast Acquisition Corp Cash Flow Conversion Ratio Explained
Waldencast Acquisition Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Waldencast Acquisition Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Waldencast Acquisition Corp ranked by their cash flow conversion efficiency. Also see Waldencast Acquisition Corp (WALDW) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aquis Exchange PLC
LSE:AQX
|
0.057x |
|
Lexaria Bioscience Corp
NASDAQ:LEXXW
|
-0.218x |
|
Jasmine International Public Company Limited
F:JASN
|
0.020x |
|
Clene Inc
NASDAQ:CLNNW
|
0.322x |
|
BriaCell Therapeutics Corp
NASDAQ:BCTXW
|
-0.270x |
|
Ucommune International Ltd
NASDAQ:UKOMW
|
-0.017x |
|
immatics biotechnologies GmbH
NASDAQ:IMTXW
|
-0.064x |
|
Neovacs S.A.
PA:ALNEV
|
-0.144x |
Annual Cash Flow Conversion Efficiency for Waldencast Acquisition Corp (2020–2025)
The table below shows the annual cash flow conversion efficiency of Waldencast Acquisition Corp from 2020 to 2025. Review WALDW cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $500.10 Million | $-12.82 Million | -0.026x | -112.09% |
| 2024-12-31 | $729.94 Million | $-8.82 Million | -0.012x | +68.78% |
| 2023-12-31 | $769.27 Million | $-29.77 Million | -0.039x | -143.04% |
| 2021-12-31 | $39.24 Million | $3.53 Million | 0.090x | -99.99% |
| 2020-12-31 | $-10.95K | $-7.43 Million | 678.568x | -- |
About Waldencast Acquisition Corp
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; co… Read more